Cargando…
Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
Autor principal: | Kim, Hungdai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Coloproctology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564662/ https://www.ncbi.nlm.nih.gov/pubmed/26361612 http://dx.doi.org/10.3393/ac.2015.31.4.121 |
Ejemplares similares
-
Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
por: Ye, Byong Duk
Publicado: (2014) -
Fluid Therapy from Friend to Foe
por: Fodor, Raluca
Publicado: (2023) -
Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
por: Guidotti, Giulia, et al.
Publicado: (2021) -
Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022) -
Role of mesenteric component in Crohn’s disease: A friend or foe?
por: Yin, Yi, et al.
Publicado: (2021)